SNY CHMP opinion: Thursday, September 17, 2026
Variation type II · Teizeild · Update of section 4.4 of the SmPC in order to update the existing warning on serious infections in order to add Epstein-Barr Virus (EBV) reactivation in patients with co-morbid conditions predisposing them to significant immunocompromise, based on a safety evaluation r
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.